Ideaya and Biocytogen ink $400M+ deal; Daiichi spends more on superstar ADCs

Plus, news about PepGen, Lilly, Abcellera, CastleVax and Tracon:

Ideaya and Biocytogen ink deal worth $400M+: At the center of the deal is a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Study could explain why astronauts’ T cells become less effective at fighting infection

A new study led by researchers at Karolinska Institutet in Sweden has examined how T cells of the immune system are affected by weightlessness.

August 26, 2023

New Monthly Paliperidone Palmitate Injectable OK’d for Schizophrenia

The FDA approved a new monthly paliperidone palmitate (Erzofri) extended-release injectable suspension for treating schizophrenia in adults, Luye Pharma announced. An atypical antipsychotic, paliperidone palmitate

July 30, 2024

Pharmalittle: We’re reading about India-made versions of Wegovy, an RSV vaccine scramble, and more

Top of the morning to you, and a fine one it is. Clear blue skies are hovering over the Pharmalot campus, where a cool breeze

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.